Hideo Baba

1988–2025 年に発表

340
論文数
36,605
被引用数
108
h 指数
329
i10 指数

被引用数

Hideo Baba の年別被引用数1989 年: 被引用 2 件1990 年: 被引用 4 件1991 年: 被引用 3 件1992 年: 被引用 6 件1993 年: 被引用 2 件1994 年: 被引用 4 件1995 年: 被引用 10 件1996 年: 被引用 13 件1997 年: 被引用 10 件1998 年: 被引用 11 件1999 年: 被引用 13 件2000 年: 被引用 30 件2001 年: 被引用 25 件2002 年: 被引用 36 件2003 年: 被引用 42 件2004 年: 被引用 29 件2005 年: 被引用 28 件2006 年: 被引用 29 件2007 年: 被引用 53 件2008 年: 被引用 56 件2009 年: 被引用 72 件2010 年: 被引用 89 件2011 年: 被引用 94 件2012 年: 被引用 109 件2013 年: 被引用 175 件2014 年: 被引用 164 件2015 年: 被引用 219 件2016 年: 被引用 298 件2017 年: 被引用 334 件2018 年: 被引用 338 件2019 年: 被引用 1,377 件2020 年: 被引用 1,779 件2021 年: 被引用 1,861 件2022 年: 被引用 1,579 件2023 年: 被引用 1,291 件2024 年: 被引用 2,034 件2025 年: 被引用 933 件2026 年: 被引用 32 件

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,982 件、この内訳の 23.7%アメリカ合衆国: 引用元論文 2,994 件、この内訳の 17.8%日本: 引用元論文 1,985 件、この内訳の 11.8%イタリア: 引用元論文 715 件、この内訳の 4.2%ドイツ: 引用元論文 643 件、この内訳の 3.8%イギリス: 引用元論文 635 件、この内訳の 3.8%韓国: 引用元論文 498 件、この内訳の 3%フランス: 引用元論文 433 件、この内訳の 2.6%スペイン: 引用元論文 350 件、この内訳の 2.1%カナダ: 引用元論文 342 件、この内訳の 2%オランダ: 引用元論文 310 件、この内訳の 1.8%インド: 引用元論文 282 件、この内訳の 1.7%
0%23.7%その他 21.7%

分野

  • Medicine60.2%
  • Biochemistry, Genetics and Molecular Biology29.3%
  • Immunology and Microbiology6.1%
  • Dentistry0.8%
  • Neuroscience0.8%
  • Engineering0.7%
  • その他2.1%

トピック

  • Cancer Immunotherapy and Biomarkers4.4%
  • Gastric Cancer Management and Outcomes3.3%
  • Pancreatic and Hepatic Oncology Research3.1%
  • Esophageal Cancer Research and Treatment2.6%
  • Gut microbiota and health2.5%
  • Nutrition and Health in Aging2.3%
  • その他81.8%

共著者

全論文

検索で開く
  1. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

    著者: , , , , , , , , - Cancer Treatment Reviews 2017 被引用: 1,642

  2. Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2015 被引用: 1,074

  3. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean–Luc Van Laethem, Eric Van Cutsem, Scott Berry, Mark Vincent, Bettina Müller, Felipe Rey, Ángela R. Zambrano, Joaquín Guerra, Merete Krogh, Lene Bæksgaard, Mette Yilmaz, Anneli Elme, Andrus Magi, Päivi Auvinen, Tuomo Alanko, Markus Moehler, Volker Kunzmann, Thomas Seufferlein, Peter Thuss-Patience, Eray Goekkurt, Thomas Hoehler, Georg Martin Haag, Salah‐Eddin Al‐Batran, Hugo R. Castro, Karla Alejandra Lopez, Mynor Aguilar Vasquez, Mario Sandoval, Ka On Lam, Sinéad Cuffe, Cathy Kelly, Ravit Geva, Einat Shacham‐Shmueli, Ayala Hubert, Alex Beny, Baruch Brenner, Giuseppe Aprile, Alfredo Falcone, Evaristo Maiello, Rodolfo Passalacqua, Vincenzo Montesarchio, Hiroki Hara, Keisho Chìn, Tomohiro Nishina, Yoshito Komatsu, Nozumo Machida, Shuichi Hironaka, Taroh Satoh, Takao Tamura, Naotaoshi Sugimoto, Haruhiko Cho, Yashushi Omuro, Ken Kato, Masahiro Goto, Ichinosuke Hyodo, Kazuhiro Yoshida, Hideo Baba, Taito Esaki, Junji Furuse, Wan Zamaniah Wan Mohammed, Carlos Hernández Hernández, Juan Casas Garcia, Adriana Dominguez Andrade, Katriona Clarke, Geir Olav Hjortland, Nils Glenjen, Tomasz Kubiatowski, Jassem Jacek, Marek Z. Wojtukiewicz, Sergey Lazarev, Yuri Lancukhay ほか 58 名 - The Lancet 2018 被引用: 1,316

  4. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis

    著者: , , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 455

  5. CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2011 被引用: 1,187

  6. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 被引用: 157

  7. Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer

    著者: , , , , , , , , , - Annals of Surgery 2018 被引用: 394

  8. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment

    著者: , , , , , , , - Oncogene 2019 被引用: 351

  9. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma

    著者: , , , , , , , , - Clinical Cancer Research 2019 被引用: 199

  10. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2020 被引用: 129

  11. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynnette Marie Sholl, Ewa Sicińska, Jacob Sands, Scott J. Rodig, Kwok‐Kin Wong, Cloud P. Paweletz, Hideo Watanabe, David A. Barbie - Nature Medicine 2018 被引用: 317

  12. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2023 被引用: 96

  13. Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐ MITSUBA)

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepato-Biliary-Pancreatic Sciences 2022 被引用: 237

  14. Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Giannakis, Shuji Ogino - Gastroenterology 2022 被引用: 109

  15. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takehito Otsubo, Shin Ishihara, Takeshi Takahara, Mitsuo Shimada, Michiaki Unno, M Imamura, Nobuhiro Ohkochi, Yoshiaki Murakami, Jiro Fujimoto, Shinichi Ikuta, Y Fujino, Minoru Uebayashi, Shuichi Ishiyama, Norihisa Takakura, Yusuke Kumamoto, Takehito Kato, Isaku Yoshioka, Shinji Üemoto, Katsuhiko Yanaga - British journal of surgery 2018 被引用: 395

  16. Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Research 2020 被引用: 154

  17. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway

    著者: , , , , , , , , , , , , , , , - Cancer Letters 2022 被引用: 109

  18. Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2022 被引用: 97

  19. B cell and B cell-related pathways for novel cancer treatments

    著者: , , , , , , , , , - Cancer Treatment Reviews 2018 被引用: 262

  20. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis

    著者: , , , , , , , , , , , , , , , , - Cancer Science 2021 被引用: 75

  21. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 193

  22. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer

    著者: , , , , , , , , , - Molecular Cancer 2022 被引用: 122

  23. Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kazuhiko Koike, Masahiro Kobayashi, Takaaki Higashi, Shigeki Nakagawa, Yo‐ichi Yamashita, Toru Beppu, Hideo Baba, Hiromitsu Kumada, Kazuaki Chayama, Thomas F. Baumert, Yujin Hoshida - Science Translational Medicine 2022 被引用: 115

  24. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells

    著者: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2017 被引用: 241